Analyzing Lung Sounds in Patients with Lung Diseases
Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · NCT06399094
This study is testing if an electronic stethoscope can help doctors hear and measure lung sounds better in patients with cystic fibrosis, pulmonary fibrosis, or COPD to improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Groupe Hospitalier de la Region de Mulhouse et Sud Alsace (other) |
| Locations | 2 sites (Strasbourg, Bas-Rhin and 1 other locations) |
| Trial ID | NCT06399094 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the detection and quantification of pathological lung sounds in patients with cystic fibrosis, pulmonary fibrosis, or COPD using an electronic stethoscope. It will evaluate the ability to detect changes in lung sounds and quantify the severity of these sounds through advanced time-frequency analysis and artificial intelligence. The study will involve 60 patients aged 18 to 65 during their routine consultations, where lung sound recordings will be made at predefined pulmonary sites. The data collected will help improve monitoring and management of these conditions.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 with cystic fibrosis, pulmonary fibrosis, or COPD who are undergoing routine follow-up consultations.
Not a fit: Patients with a history of thoracic surgery, thoracic deformity, or significant heart failure may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the monitoring of lung conditions and lead to better management strategies for patients.
How similar studies have performed: While the approach of using electronic stethoscopes and AI for lung sound analysis is innovative, similar studies have shown promise in improving lung disease monitoring.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Suffering from one of the following pathologies: cystic fibrosis, pulmonary fibrosis, COPD * Not opposed to participating in the study Exclusion Criteria: * Person under court protection, guardianship or curatorship * Person deprived of liberty by judicial or administrative decision * Patient with a history of thoracic surgery, thoracic deformity, heart failure or other relevant illness at the investigator's discretion.
Where this trial is running
Strasbourg, Bas-Rhin and 1 other locations
- Hôpitaux Universitaire de Strasbourg — Strasbourg, Bas-Rhin, France (RECRUITING)
- GHRMSA - Hôpital Emile Muller — Mulhouse, Haut-Rhin, France (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis